Symbols

CNTX

Context Therapeutics·NASDAQ

--(--)

CNTX Profile

Context Therapeutics Inc.

A biopharmaceutical company focused on developing hormone therapies for cancer treatment

Industry

Pharmaceutical

Established Date

Listing Date

10/20/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.contexttherapeutics.com

Security Type

Common stock

Office address

2001 Market Street, Suite 3915, Unit #15, Philadelphia, Pennsylvania 19103

Business

Introduction

Context Therapeutics Inc., was incorporated in Delaware in April 2015. The company is a clinical-stage biopharmaceutical company advancing T-cell-bridging bispecific antibodies for solid tumors. Its R&D pipeline includes CTIM-76 targeting CLDN 6, CT-95 targeting mesothelin, and CT-202 targeting Nectin-4, and these drug candidates are in or planned for Phase 1 clinical trials.